Australasian marsupials, especially wallabies, are highly susceptible to clinical toxoplasmosis. This paper describes the use of atovaquone for effective treatment of toxoplasmosis in 4 Bennett's wallabies (Macropus rufogriseus), along with the serology, isolation of Toxoplasma gondii, and genotyping of 3 T. gondii isolates from 5 captive wallabies. This is the first report of success in treating acute toxoplasmosis in wallabies, the first report of serology followed over a significant period of time, and the first report of isolation and genetic typing of T. gondii from wallabies in the United States.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.